<VariationArchive RecordType="classified" VariationID="371085" VariationName="NM_000642.3(AGL):c.4322_4323dup (p.Gly1442fs)" VariationType="Duplication" Accession="VCV000371085" Version="5" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2023-11-20" DateCreated="2017-01-06" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357224" VariationID="371085">
      <GeneList>
        <Gene Symbol="AGL" FullName="amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" GeneID="178" HGNC_ID="HGNC:321" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="99849258" stop="99924023" display_start="99849258" display_stop="99924023" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="100315639" stop="100389578" display_start="100315639" display_stop="100389578" Strand="+" />
          </Location>
          <OMIM>610860</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000642.3(AGL):c.4322_4323dup (p.Gly1442fs)</Name>
      <CanonicalSPDI>NC_000001.11:99916470:AAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="99916470" stop="99916471" display_start="99916470" display_stop="99916471" variantLength="2" positionVCF="99916470" referenceAlleleVCF="T" alternateAlleleVCF="TAA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="100382026" stop="100382027" display_start="100382026" display_stop="100382027" variantLength="2" positionVCF="100382026" referenceAlleleVCF="T" alternateAlleleVCF="TAA" />
      </Location>
      <ProteinChange>G1426fs</ProteinChange>
      <ProteinChange>G1442fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.100382028_100382029dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.100382028_100382029dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.99916472_99916473dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.99916472_99916473dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012865.1" sequenceAccession="NG_012865" sequenceVersion="1" change="g.71389_71390dup">
            <Expression>NG_012865.1:g.71389_71390dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000028.3" sequenceAccession="NM_000028" sequenceVersion="3" change="c.4322_4323dup">
            <Expression>NM_000028.3:c.4322_4323dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000019.2" sequenceAccession="NP_000019" sequenceVersion="2" change="p.Gly1442Lysfs">
            <Expression>NP_000019.2:p.Gly1442Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000642.3" sequenceAccession="NM_000642" sequenceVersion="3" change="c.4322_4323dup" MANESelect="true">
            <Expression>NM_000642.3:c.4322_4323dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000633.2" sequenceAccession="NP_000633" sequenceVersion="2" change="p.Gly1442fs">
            <Expression>NP_000633.2:p.Gly1442fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000643.3" sequenceAccession="NM_000643" sequenceVersion="3" change="c.4322_4323dup">
            <Expression>NM_000643.3:c.4322_4323dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000634.2" sequenceAccession="NP_000634" sequenceVersion="2" change="p.Gly1442Lysfs">
            <Expression>NP_000634.2:p.Gly1442Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000644.3" sequenceAccession="NM_000644" sequenceVersion="3" change="c.4322_4323dup">
            <Expression>NM_000644.3:c.4322_4323dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000635.2" sequenceAccession="NP_000635" sequenceVersion="2" change="p.Gly1442Lysfs">
            <Expression>NP_000635.2:p.Gly1442Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000646.3" sequenceAccession="NM_000646" sequenceVersion="3" change="c.4274_4275dup">
            <Expression>NM_000646.3:c.4274_4275dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000637.2" sequenceAccession="NP_000637" sequenceVersion="2" change="p.Gly1426Lysfs">
            <Expression>NP_000637.2:p.Gly1426Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425325.1" sequenceAccession="NM_001425325" sequenceVersion="1" change="c.4322_4323dup">
            <Expression>NM_001425325.1:c.4322_4323dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412254.1" sequenceAccession="NP_001412254" sequenceVersion="1" change="p.Gly1442Lysfs">
            <Expression>NP_001412254.1:p.Gly1442Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425326.1" sequenceAccession="NM_001425326" sequenceVersion="1" change="c.4301_4302dup">
            <Expression>NM_001425326.1:c.4301_4302dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412255.1" sequenceAccession="NP_001412255" sequenceVersion="1" change="p.Gly1435Lysfs">
            <Expression>NP_001412255.1:p.Gly1435Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425327.1" sequenceAccession="NM_001425327" sequenceVersion="1" change="c.4121_4122dup">
            <Expression>NM_001425327.1:c.4121_4122dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412256.1" sequenceAccession="NP_001412256" sequenceVersion="1" change="p.Gly1375Lysfs">
            <Expression>NP_001412256.1:p.Gly1375Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425328.1" sequenceAccession="NM_001425328" sequenceVersion="1" change="c.4118_4119dup">
            <Expression>NM_001425328.1:c.4118_4119dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412257.1" sequenceAccession="NP_001412257" sequenceVersion="1" change="p.Gly1374Lysfs">
            <Expression>NP_001412257.1:p.Gly1374Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425329.1" sequenceAccession="NM_001425329" sequenceVersion="1" change="c.3983_3984dup">
            <Expression>NM_001425329.1:c.3983_3984dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412258.1" sequenceAccession="NP_001412258" sequenceVersion="1" change="p.Gly1329Lysfs">
            <Expression>NP_001412258.1:p.Gly1329Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001425332.1" sequenceAccession="NM_001425332" sequenceVersion="1" change="c.3944_3945dup">
            <Expression>NM_001425332.1:c.3944_3945dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001412261.1" sequenceAccession="NP_001412261" sequenceVersion="1" change="p.Gly1316Lysfs">
            <Expression>NP_001412261.1:p.Gly1316Lysfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16040848" DB="ClinGen" />
        <XRef Type="rs" ID="1057516994" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000642.3(AGL):c.4322_4323dup (p.Gly1442fs) AND Glycogen storage disease type III" Accession="RCV000409602" Version="5">
        <ClassifiedConditionList TraitSetID="6278">
          <ClassifiedCondition DB="MedGen" ID="C0017922">Glycogen storage disease type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-09-19" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000642.3(AGL):c.4322_4323dup (p.Gly1442fs) AND not provided" Accession="RCV000481572" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-11-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-19" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2017-01-06" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11977176</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28888851</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31661040</ID>
        </Citation>
        <DescriptionHistory Dated="2017-04-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6278" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2236" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Forbes disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cori disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limit dextrinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylo-1,6-glucosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen debrancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease type III</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+3/3123" DB="Genetic Alliance" />
                <XRef ID="66937008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD3</ElementValue>
                <XRef Type="MIM" ID="232400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most common subtype, present in about 85% of affected individuals; it manifests with liver and muscle involvement. GSD IIIb, with liver involvement only, comprises about 15% of all affected individuals. In infancy and early childhood, liver involvement presents as hepatomegaly and failure to thrive, with fasting ketotic hypoglycemia, hyperlipidemia, and elevated hepatic transaminases. In adolescence and adulthood, liver disease becomes less prominent. Most individuals develop cardiac involvement with cardiac hypertrophy and/or cardiomyopathy. Skeletal myopathy manifesting as weakness may be evident in childhood and slowly progresses, typically becoming prominent in the third to fourth decade. The overall prognosis is favorable but cannot be predicted on an individual basis. Long-term complications such as muscular and cardiac symptoms as well as liver fibrosis/cirrhosis and hepatocellular carcinoma may have a severe impact on prognosis and quality of life. To date, it is unknown if long-term complications can be alleviated and/or avoided by dietary interventions.</Attribute>
                <XRef ID="NBK26372" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9442" />
                <XRef ID="9442" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301788</ID>
                <ID Source="BookShelf">NBK26372</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2010">
                <ID Source="PubMed">20631546</ID>
              </Citation>
              <XRef ID="366" DB="Orphanet" />
              <XRef ID="C0017922" DB="MedGen" />
              <XRef ID="MONDO:0009291" DB="MONDO" />
              <XRef Type="MIM" ID="232400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1103901" SubmissionDate="2017-11-28" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:746603|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000568794" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.4322_4323dupAA pathogenic variant in the AGL gene has been reported previously using alternate nomenclature (c.4323_4324insAA or c.4724insAA), either in the homozygous state or in combination with another AGL variant, in several individuals with a diagnosis of glycogen storage disease type III confirmed by enzyme analysis (Decostre et al., 2016; Lucchiari et al., 2002). The c.4322_4323dupAA variant causes a frameshift starting with codon Glycine 1442, changes this amino acid to a Lysine residue, and creates a premature Stop codon at position 28 of the new reading frame, denoted p.Gly1442LysfsX28. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.4322_4323dupAA variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.4322_4323dupAA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4322_4323dupAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4028748" SubmissionDate="2022-01-10" DateLastUpdated="2022-01-12" DateCreated="2022-01-12">
        <ClinVarSubmissionID localKey="NM_000642.3:c.4322_4323dup|OMIM:232400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002055511" DateUpdated="2022-01-12" DateCreated="2022-01-12" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.3:c.4322_4323dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10918493</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5068667" SubmissionDate="2022-10-13" DateLastUpdated="2022-11-05" DateCreated="2022-11-05">
        <ClinVarSubmissionID localKey="NM_000642.2:c.4322_4323dupAA|MedGen:C0017922" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002598667" DateUpdated="2022-11-05" DateCreated="2022-11-05" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28888851</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31661040</ID>
          </Citation>
          <Comment>Variant summary: AGL c.4322_4323dupAA (p.Gly1442LysfsX28) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 250644 control chromosomes (gnomAD). c.4322_4323dupAA has been reported in the literature in individuals affected with Glycogen Storage Disease Type III (examples: Laforet_2019 and Decostre_2017). These data indicate that the variant is likely to be associated with disease. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4322_4323dupAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017922" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12153506</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="950309" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="25203|OMIM:232400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000486559" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11977176</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000642.2:c.4322_4323dupAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5068667" TraitType="Disease" MappingType="XRef" MappingValue="C0017922" MappingRef="MedGen">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="950309" TraitType="Disease" MappingType="XRef" MappingValue="232400" MappingRef="OMIM">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4028748" TraitType="Disease" MappingType="XRef" MappingValue="232400" MappingRef="OMIM">
        <MedGen CUI="C0017922" Name="Glycogen storage disease type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1103901" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

